White label ELPA - ClinicalTrials.eu

Standardization of Olea europaea pollen extract for patients with olive pollen allergies

Recruiting

2 1 1
Investigated Diseases:
- Hypersensitivity
Investigated Drugs:
Study of the effects of stopping elranatamab and teclistamab treatment in patients with multiple myeloma who have had a significant response to therapy.

Recruiting

2 1 1 1
Investigated Drugs:
- Elranatamab
- Teclistamab
An observational study of carbidopa and levodopa use with a new dispensing device and app in patients with Parkinson’s disease

Recruiting

3 1 1 1
Investigated Drugs:
- Carbidopa
- Levodopa
Study of chlorhexidine, metronidazole, and FB301 for the treatment of women with bacterial vaginosis

Recruiting

2 1 1 1
Investigated Diseases:
- Bacterial vaginosis
Investigated Drugs:
- Chlorhexidine Gluconate
- Metronidazole
Evaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older

Recruiting

3 1 1
Investigated Drugs:
- Recombinant Varicella Zoster Virus Glycoprotein E
A study to evaluate the effectiveness and safety of iadademstat in adults with essential thrombocythemia who do not respond well to or cannot tolerate hydroxyurea

Recruiting

2 1 1
Investigated Diseases:
- Essential thrombocythaemia
Investigated Drugs:
- IADADEMSTAT
Study of the effect of hyperbaric oxygen therapy on the bacteria in chronic wounds

Recruiting

3 1 1 1
Investigated Drugs:
- Oxygen
A study of donidalorsen for children with hereditary angioedema

Recruiting

3 1 1
Investigated Diseases:
- Hereditary angioedema
Investigated Drugs:
- Donidalorsen
A study comparing the effectiveness of a simeticone drug combination and a sodium picosulfate drug combination for bowel preparation in patients undergoing colorectal cancer screening.

Recruiting

3 1 1 1
Investigated Drugs:
A study to evaluate the safety and efficacy of ivosidenib, decitabine, and cedazuridine in adults with newly diagnosed acute myeloid leukemia who are older than 60 or cannot receive intensive chemotherapy.

Recruiting

2 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies